For example, the deletion of the miR-15a/16-1 cluster and the primary transcript Leu-2 in chromosome 13 in B-cells of chronic lymphocytic leukemia (CLL) patients allows higher expression of its target, BCL2, an anti-apoptotic protein [26,28]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.